World Heart Journal

Co-Editors-in-Chief: R.B. Singh and Germaine Cornelissen
ISSN: 1556-4002
Frequency: Quarterly
Print Binding: Softcover
Print Size: 8.5″ x 11″, Double column

It is the aim of WHJ to help advance research in the world of cardiology by publishing papers on the following topics: Epidemiology and Prevention; Chronocardiology and Chronomics; Nutrition and Lifestyle in CVD; Clinical Cardiology; Cardiovascular Sciences (Molecular Cardiology: Biochemistry and Biology); Hypertension; Coronary Artery Disease; Pharmacotherapy; Electrophysiology; Echocardiography; Nuclear Cardiology; Pediatric Cardiology; Geriatric Cardiology; CVD in Women; Cardiac Rehabilitation and Prehabilitation; as well as Interventional Cardiology and Cardiac Surgery.

Sponsoring Organizations
BIOCOS Group (USA)
International College of Cardiology (Slovakia)
International College of Nutrition (India)

Categories: ,

Table of Contents

Volume 14 Issue 4 – In Production
Volume 14 Issue 3 – In Production
Volume 14 Issue 2
Volume 14 Issue 1
Volume 13 Issue 4
Volume 13 Issue 3
Volume 13 Issue 2
Volume 13 Issue 1
Volume 12 Issue 4
Volume 12 Issue 3
Volume 12 Issue 2
Volume 12 Issue 1
Volume 11 Issue 4
Volume 11 Issue 3
Volume 11 Issue 2
Volume 11 Issue 1
Volume 10 Issue 4
Volume 10 Issue 3
Volume 10 Issue 2
Volume 10 Issue 1
Volume 9 Issue 4
Volume 9 Issue 3
Volume 9 Issue 2
Volume 9 Issue 1
Volume 1 Issue 1

Founding Editor

Late Dr. Franz Halberg, MD
Professor of Chronobiology, Halberg Chronobiology Center
Department of Pathology and Laboratory Medicine
University of Minnesota
Minneapolis, MN, USA

Co-Editors-in-Chief

Dr. Germaine Cornelissen, PhD
Professor, Integrative Biology and Physiology
Co-Director, Halberg Chronobiology Center
University of Minnesota
Minneapolis, MN, USA
E-mail: corne001@umn.edu

Dr. Ram B Singh, MBBS, MD (Intern Med-Cardiol)
Professor Internal Medicine, Halberg Hospital and Research Institute
Moradabad (UP) 244001, India
E-mail: rbs@tsimtsoum.net

Editors

Dr. Krasimira Hristova, MD, PhD
Cardiologist, Department of Cardiology
National University Hospital
Sofia, Bulgaria
khristovabg@yahoo.com

Dr. Galal Eldin Nagib-Elkilany, MD, PhD
Gulf Medical University
Ajman, UAE

Dr. Jan Fedacko, MD
Assistant Professor, Department of Internal Medicine
PJ Safaric University
Kosice, Slovakia
Janfedacko@hotmail.com

Dr. Jaipaul Singh, PhD, DSc
School of Forensic and Applied Sciences
University of Central Lancashire
Preston, Lancashire, England
jsingh3@uclan.ac.uk

Associate Editors

Dr. Chee-Oon Kong, MD
Professor of Medicine
National Yang-Ming University
Taipei, Taiwan
cwkong@vghtpe.gov.tw

Dr. Sergey Chibisov, MD, PhD
Professor of Chronomedicine
Peoples’ Friendship University of Russia
Moscow, Russia
kalcna@mail.ru

Dr. Rajeev Gupta, MD, DM, MRCP
Consultant Cardiologist
Al Noor Hospital
Al Ain, UAE
rajeevsavita.gupta@gmail.com

Dr. Pasquale Palmiero, MD
Heart Station and Echocardiography Laboratory
ASL Brindisi, Italy
pasqualepalmiero@iciscu.org

Assistant Editors

Dr. Toru Takahashi, PhD
Department of Nutrition
Graduate School of Human Environment Science
Fukuoka Women’s University
Fukuoka, Japan
takahashi@fwu.ac.jp

Dr. Viliam Mojto, MD, PhD
3rd Department of Internal Medicine
Comenius University
Bratislava, Russia

Dr. Sherif Baathallah, MD
\RAK Hospital
Fujairah, UAE

Dr. Mohammed Elmahal, MSc, MRCP(UK)
Medical Director, Masafi Hospital
UAE

Dr. Ehab E.Tuppo, DO, PhD, MPH
Cardiovascular Institute of New Jersey
USA

Editorial Secretaries

Dr. Adrian Isaza
Everglade University
Tampa, Florida, USA

Dr. Tanya Sharma
University of Arkansas for Medical Sciences
Little Rock, Arkansas, USA
TSharma@uams.edu

Dr. Srishti Singh Visen; MD
Brookdale University Hospital and Medical Centre
Brooklyn, New York, USA

Editorial Board Members

Dr. J L Mehta, MD, PhD
Distinguished Professor of Medicine and Physiology and Cell Biology
Stebbins Chair in Cardiology, University of Arkansas for Medical Sciences
VA Central Office Senior Clinician Scientist,
Little Rock, Arkansas, USA

Dr. Tsui-Lieh Hsu, MD
Taiwan Society of Cardiology
Taipei, Taiwan
tlhsu@vghtpe.gov.tw

Dr. Eri Toda
Department of Cardiology
Tokai University Hachioji Hospital
Tokyo, Japan
eritoda@is.icc.u-tokai.ac.jp

Dr. Hideki Mori, MD, FICC
Aomori Prefectural Central Hospital
Aomori City, Japan

Dr. Fabien De Meester
Executive Director, The Tsim Tsoum Institute
Krakow, Poland
fdm@tsimtsoum.net

Dr. Brian Tomlinson, MD
Professor of Internal Medicine
The Chinese University of Hong Kong
Shatin, Hong Kong
btomlinson@cuhk.edu.hk

Dr. T K Basu, PhD
University of Alberta
Edmonton, Canada
Tapan.Basu@ualberta.com

Dr. Rakesh Sharma, PhD
Department of MRI Imaging
Florida University
Florida, USA
rksz2009@gmail.com

Dr. M L Garg, PhD
Professor, School of Biomedical Sciences and Pharmacy
The University of Newcastle
Australia
Manohar.Garg@newcastle.edu.au

Dr. Hilton Chaves, MD, PhD
Professor, Division of Cardiology
Department of Internal Medicine
Federal University of Pernambuco
Recife, Brazil
hchavesjr@gmail.com

Dr. Jong Lee, MD, PhD
Department of Medicine
University of Minnesota Medical School
Minneapolis, Minnesota, USA

Dr. Anna Gvozdjakova, PhD, DSc
Pharmacobiochemical Laboratory
3rd Department of Internal Medicine
Comenius University
Bratislava, Slovakia

Professor Chris Howarth
Department of Physiology
College of Medicine & Health Sciences
UAE University
Al Ain, UAE
chris.howarth@uaeu.ac.ae

Dr. Marco Piciche, MD, PhD
Consultant Cardiac Surgeon
Rome, Italy
marco.piciche@libero.it

Dr. Mai Elnaggar, MD
Consultant Endocrinology
Cairo University
Maielnaggar203@gmail.com

Dr. NS Neki, MD, FICN
Professor, Government Medical College
Amritsar, India

Dr. Branislav Milovanovic, MD, PhD
Neurocardiological Laboratory
Department of Cardiology
University Clinical Center Bezanijska Kosa
University of Belgrade
Serbia
branislav_milovanovic@vektor.net

Dr. Jaipaul Singh, PhD, DSc
School of Forensic and Applied Sciences
University of Central Lancashire
Preston, Lancashire, England
jsingh3@uclan.ac.uk

Dr. Hisham Mohd Aboul-Enein, MD
Vice President, Benha University
Cairo, Egypt
haenin@yahoo.com

Dr. Chee Jeong Kim, MD
Professor, Division of Cardiology
College of Medicine
Chung-Ang University
Seoul, Korea
cjkim@cau.ac.kr

Dr. Elliot Berry, MD
Department of Human Nutrition and Metabolism
Braun School of Public Health
Hebrew University-Hadassah Medical School
Jerusalem, Israel

Dr. Viliam Mojto, MD, PhD
Department of Internal Medicine
Comenium University
Slovakia

Dr. Gal Dubnov, MD
Department of Human Nutrition and Metabolism
Braun School of Public Health
Hebrew University-Hadassah Medical School
Jerusalem, Israel

Dr. Sergey Chibisov, MD, PhD
Peoples’ Friendship University of Russia
Moscow, Russia

Dr. Michail Blagonravov, MD, PhD
Peoples’ Friendship University of Russia
Moscow, Russia

Dr. S Chaithiraphan, MD
President Chaophya Hospital
Director of Cardiac Center
Bankok, Thailand

Dr. Rody G Sy, MD
Cardinal Santos Medical Center
Metro Manila, Philippines

Dr. Kaumudi Joshipura, DSc
Department of Epidemiology
Harvard School of Public Health
Boston, USA
kjoshipu@hsph.harvard.edu

Dr. C E Chiang, MD
Division of Cardiology
Department of Medicine
Taipei Veterans General Hospital and National Yang-Ming University School of Medicine
Taipei, Taiwan
cechiang@vghtpe.gov.tw

Dr. Antonis Zampelas, PhD
Professor in Human Nutrition
Agricultual University of Athens
Athens, Greece

Dr. H R Gundurao, PhD
Department of Pathology and Laboratory Medicine
University of Minnesota Medical School
Minneapolis, Minnesota, USA

Dr. C M Yu, MD
Division of Cardiology
Chinese University of Hong Kong
Hong Kong
medt@cuhk.edu.hk

Viola Mechirova, MD, PhD
Department of Internal Medicine
PJ Safaric University
Kosice, Slovakia

Dr. M L Burr, MD
Centre for Applied Public Health Medicine
University of Wales College of Medicine
Temple of Peace and Health
Cathays Park, Cardiff, UK

Dr. Agnieszka Wilczynska, PhD
Department of Psychology
University of Silesia
Krakow, Poland

Dr. Adarsh Kumar, MD, DM
Professor of Cardiology
Department of Internal Medicine
Government Medical College
Amritsar, India

Dr. Kuniaki Otsuka, MD, PhD
Professor Emeritus
Department of Chronomics and Gerontology
Tokyo Women’s Medical University
Arakawa, Tokyo, Japan
otsukagm@dnh.twmu.ac.jp

Dr. Daniel Pella, MD
Department of Internal Medicine
PJ Safaric University
Kosice, Slovakia
daniel.pella@upjs.sk

Editorial Advisers

Dr. Liu Lisheng, MD
Professor of Cardiology
Cardiovascular Institute and Fu Wai Hospital
Beijing, China.

Dr. Akira Yamamoto, MD
Professor of Internal Medicine and Founder
Asian Pacific Society of Atherosclerosis and Vascular Diseases
Osaka, Japan

Dr. E D Janus, MD
Founder Secretary General
Asian Pacific Society of Atherosclerosis and Vascular Diseases
Australia

Dr. Rodolfo Paoletti, MD
Professor of Pharmacology
Institute of Pharmacology
Milan, Italy

Dr. Jim Shepherd
Editor, Atherosclerosis
UK

Dr. NS Dhalla, MD (Hon), DSc
Professor of Cardiovascular Sciences
St. Boniface Hospital Institute of Cardiovascular Sciences
Winnipeg, Canada
nsdhalla.@sbrc.ca

Dr. Shashank Joshi, MD, DM
Leelawati Hospital
Mumbai, India
shashank.sr@gmail.com

Statistical Editor

Prof. Dr. Douglas W Wilson, PhD, DSc
Chronobiology and Statistics
Formerly, School of Medicine, Pharmacy and Health
Durham University
Durham, UK
d.w.wilson@durham.ac.uk

Referees: Volunteers

Dr. Neha Singh, PhD
David Geffen School of Medicine
UCLA
Los Angeles, California, USA
senger.neha@gmail.com

Dr. Geir Bjørklund, MD (Scholar)
Council for Nutritional and Environmental Medicine
Mo i Rana, Norway
bjorklund@conem.org

Dr. MPM Vester
Leiden University Medical Center
Leiden, The Netherlands
M.P.M.Vester@lumc.nl

Sponsors

BIOCOS Group (USA)
International College of Cardiology (Slovakia) www.iccsk.com
International College of Nutrition (India) www.icnhealthfoods.com

NOTES FOR CONTRIBUTORS

World Heart Journal is a peer-reviewed journal that publishes four issues per year. The journal is owned and operated by Nova Science Publishers and funded entirely by subscription revenue and author-optional publication services. The journal is available in print and electronic formats.

There is no charge to submit your article and have it published in the journal. Nova offers a number of optional publication services that carry fees, but authors are not required to select these services, and the services won’t be offered until after acceptance of the articles. These services include Open Access, color printing, article offprints, discounted print copies of the journal issue, and licenses for use of the published articles.

Submission of an article must be accompanied by a signed Copyright Transfer and Disclosure Form, which can be printed or downloaded here: https://novapublishers.com/wp-content/uploads/2021/09/CTDF-Copyright-Transfer-and-Disclosure-Form.pdf. Submissions that do not include a signed Copyright Transfer and Disclosure Form will be treated as incomplete.

Authors will receive complimentary PDFs of their final articles upon publication. Print copies are offered to authors at a discounted price.

Authors may deposit and display the proofed versions of their articles in and on their personal non-commercial and affiliate non-commercial repositories and websites at any time. The same may be done with their final published articles only after a period of one year has elapsed from the day of publication. Authors may obtain reproduction and republication rights for their articles by transacting with Copyright Clearance Center or with Nova directly.

Manuscript Submissions
Before submitting your article, please read the complete notes and instructions below to ensure that you understand Nova’s manuscript requirements and publication procedures and that you are in compliance with the ethical standards rightfully set forth by Nova, the publishing industry, and the scientific community.

Articles should be submitted by e-mail directly to one of the Editors listed below.

Dr. RB Singh, MBBS, MD (Intern Med-Cardiol)
Professor Internal Medicine, Halberg Hospital and Research Institute
Moradabad (UP) 244001, India
E-mail: rbs@tsimtsoum.net

Dr. Germaine Cornelissen, PhD
Professor, Integrative Biology and Physiology
Co-Director, Halberg Chronobiology Center
University of Minnesota
Minneapolis, MN, USA
E-mail: corne001@umn.edu

It is understood that articles submitted to the journal have not been submitted elsewhere for simultaneous publication consideration and have not been previously published, in whole or in part, unless the new article is an expansion of the original, in which case full transparency of the re-used portions must be provided. Please note that articles cannot be retracted or withdrawn after they have been published.

It is important that all authors and organizations where the research has been carried out have consented to the work’s submission and that all authors have significantly contributed.

Manuscript Preparation
Submissions should include the following items as separate files.

– Title Page
– Anonymized Manuscript

Title Page
The Title Page will remain separate from the manuscript throughout the peer-review process and will not be sent to the reviewers. The Title Page should include:

– A concise and informative title
– All authors’ complete names with academic degrees and complete affiliations
– A complete address for the corresponding author, including an e-mail address

If you have variations of the title that you would like Nova to use as the Running Head, please mark that at the beginning of the article.

Anonymized Manuscript
Please remove any identifying information, such as authors’ names or affiliations, from your manuscript before submission.

The manuscript should be typed in Times New Roman 12-point font and have the following components in numbered order and each beginning on a new page. The text should be under the headings, Abstract, Keywords, Introduction, Methods, Results, Discussion, Acknowledgements, References, Tables, and Figures. Abstracts should not exceed 250 words and should incorporate background, objective, study group, methods, results, and conclusions. At least three key words should appear under the Abstract.

Illustrations
All diagrams, photographs, illustrations, and charts (not tables) should be referred to in the text as Figures, and they should be numbered consecutively with Arabic numerals. These figures must be supplied as separate electronic files named in the format in which they were created, and they must be one of the following types: tiff, bitmap, jpeg, gif, ppt, psd, png, or eps. The resolution of these figures must be at least 300 dpi and of good contrast. Please use patterning instead of colors for all graphs and charts when possible. Each Figure should include a title and short description.

Figures must also be placed inside or at the end of the manuscript. If scanned images are used, please retain the original hard copy of the figure for possible transmission to Nova Science Publishers. If previously published figures are used, written permission from the copyright holders must be obtained and submitted along with the text indicating the copyright holder’s citation instructions. Such permissions must grant unrestricted use.

Peer-Review
Double-blind peer-review and publication decision are carried out and made by the editors-in-chief in cooperation with the editorial team. Double-blind peer-review means that the identity of the author is not revealed to the reviewer and that the identity of the reviewer is not revealed to the author. Reviewers advise the editors to accept the manuscript for publication, reject the manuscript for publication, or to request modifications be made to the manuscript before acceptance for publication.

Editorial Team
The editorial team works diligently to maintain the quality of the journal’s content, and their responsibilities are many. Together they:

• identify trending, emerging, and important topics of research within their specific fields of study;
• recruit authors of quality research for publication;
• coordinate and oversee the peer-review process;
• liaise with authors, referees, and the publisher;
• write editorials;
• perform technical and developmental editing of manuscripts;
• act as the journal’s ambassadors to the global scientific community;

Publication Ethics and Research Conduct
Nova and its editors are committed to maintaining trust in the journal, the value of authorship, and the integrity of science. Authors should be eager to help us maintain these standards. Guidelines are for transparency are provided below to help authors avoid the appearance of ethical misconduct in their research and to help ensure adherence to the best practices set forth by national and international professional and regulatory bodies.

Plagiarism
Plagiarism is a blight on the scientific community and a crime. The unauthorized use or close imitation of another’s language, text, data, ideas, or theories is prohibited. In all instances of authorized use, full credit to and representation of the original author’s work must be provided. It is the authors’ responsibility to secure permission for the use of copyrighted material.

The journal will use CrossCheck and/or other software to screen submitted articles for plagiarism and will investigate all reports and suspicions of plagiarism. Authors suspected of plagiaristic misconduct will be contacted and given the opportunity to prove the validity of their work and refute the allegations. All instances of proven plagiarism will be reported to the Publisher, the editorial office, the author’s institute, and other governing bodies as necessary. Plagiarized articles already accepted for publication will be cancelled, and plagiarized articles that have already been published will be retracted and denounced in a public erratum.

Transparency
In order to establish transparency in your research, authors must be sure to provide statements on the following items.

1) Information regarding the source(s) of the work’s funding;
2) All financial and non-financial potential conflicts of interest;
3) A statement of informed consent for all studies that involve human participants;
4) A statements of human rights for all studies that involve human participants;
5) A statement on the humane treatment and proper welfare of all animals involved in the study.

The appropriate statements are provided below. They should be included in the article’s text in a section titled Ethical Compliance. This section should immediately precede the References section.

1) Sources of Funding
Please provide the names of all funding agencies, research grants, and grant numbers.

Statement
Source of Funding: This study was funded by ____________________.

2) Potential Conflicts of Interest
Authors are required to disclose all personal and professional relationships and interests that can be viewed as potentially imparting bias in the work. Readers are entitled to this information and to their own conclusions and perceptions of conflict. Potential conflicts could be financial relationships, employment, sponsorships, public holdings, competing interests, spousal interests, personal relationships, personal beliefs, etc.

Possible or perceived conflicts of interest among peer reviewers are handled by the Editors. A request for the reviewer to disclose all possible or perceived conflicts of interest will be included with all invitations for peer-review. When possible or perceived conflicts of interest are present, peer reviewers are expected to recuse themselves. When editors, editorial board members, and other members of the editorial team have possible or perceived conflicts of interests with content that is submitted to them, they should recuse themselves and reassign their tasks to other capable members. If possible or perceived conflict of interest cannot be avoided by reassignment, it should be suggested to the submitting author that he/she submit to a different journal.

The Committee on Publication Ethics provides guidelines for investigating the suspected non-disclosure of conflicts of interest.
https://publicationethics.org/guidance/Flowcharts

The International Committee of Medical Journal Editors provides guidelines for the proper disclosure of conflicts of interest.
http://www.icmje.org/disclosure-of-interest/

Statement
a) Disclosure of Interest: The authors declare that they have no conflict of interest.

or

b) Disclosure of Interest:

3) Informed Consent
Study participants have the right to decide how the identifiable personal information gathered on them is used. It is essential that all participants (or guardians) give their written informed consent to participate in the study and its subsequent publication.

Statement
Informed consent was obtained from each individual participant involved in this study.

4) Statement of Human Rights
The wellbeing of human subjects takes precedence over the interests of science. If a study involves human participants, authors must include a statement to assure us that the study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.

Statement
This study was conducted in accordance with the 1964 Declaration of Helsinki and its subsequent amendments.

5) Statement of Animal Welfare
All studies that involve animals must contain a statement to assure us that the study and its procedures were approved by their affiliate institutional research ethics committees.

Statement
All animals involved in this study were treated in accordance with the ethical standards set forth by the institution at which the study was conducted.

Committee on Publication Ethics
Nova and its editors follow the Codes of Conduct and Best Practice Guidelines set forth by the Committee on Publication Ethics (COPE). These codes and guidelines are valuable instructions that ensure transparency and fairness in research and publishing. The single document provides steps for submissions, peer-review, confidentiality, the creation and maintenance of editorial boards, editorial responsibilities and decision-making, communication policy, appeal procedures, handling complaints and instances of misconduct, quality assurance, publishing corrections and retractions, adherence to national and international ethics guidelines, and many more aspects of the publication process.

The COPE Codes of Conduct and Best Practice Guidelines can be read at the link below. We recommend your familiarity with them while you conduct your research and publish with Nova and any other scientific publisher.
https://publicationethics.org/resources/code-conduct

If you notice any ethical misconduct in Nova’s publications, please contact us.

Publisher’s Office
Nova Science Publishers, Inc.
415 Oser Avenue, Suite N
Hauppauge, New York 11788, USA
Phone: (631) 231-7269
E-mail: nova.main@novapublishers.com

Advertising Opportunities
Please contact our office using the information above.

Archiving
The journal content is preserved electronically to ensure that access can continue in perpetuity if the journal ceases publication. Nova complies with NISO standards in the event of journal transfer between publishers.

Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!